PhageAI S.A. is privileged to announce a new cooperation with IBM by joining the Startup with IBM program.
The program is designed to help start-ups overcome the most common technology roadblocks and reach the market faster. The idea is to realize goals on your terms in the shortest amount of time and with the right technology partner. The program is open to early-stage health tech and fintech startups which are pre-Series A, less than five years old and have below $1 million in revenue.
While in this program, PhageAI will be able to use Big Data Infrastructure by accessing IBM Cloud Technology and mentoring from cloud experts.
This will allow us to boost AI research and scale up the PhageAI platform via cloud native stack, putting our mission and business on the path to phage research and therapy transformation.